Trials / Completed
CompletedNCT02208024
Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body
Phase I Study to Evaluate the Feasibility of Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety of focused radiation (Stereotactic Body Radiation Therapy, SBRT) on patients with pancreatic cancer that will be removed surgically.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic Body Radiation Therapy |
Timeline
- Start date
- 2014-08-27
- Primary completion
- 2017-10-11
- Completion
- 2019-05-12
- First posted
- 2014-08-04
- Last updated
- 2022-04-29
- Results posted
- 2021-12-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02208024. Inclusion in this directory is not an endorsement.